Skip to main content

Statin Initiative

In August 2009, the statin initiative was mailed out to 2,703 family physicians and general practitioners in BC.

In May 2012, a revised statin portrait was mailed to the remainder of eligible BC family physicians and general practitioners (1,856).


Statins are cholesterol-lowering drugs prescribed to reduce the risk of cardiovascular events. There is strong evidence supporting statin therapy among people who have had a major cardiovascular event as prevention against a subsequent event (“secondary prevention”). The evidence does not support statin therapy for those who have never had a cardiovascular event (“primary prevention”) and are not at high-risk of having a cardiovascular event. Contrary to evidence about treatment, many patients who have had an event are not on a statin, and many who have not had an event are. EQIP aims to increase the rate of prescribing for secondary prevention, and decrease the rate of unnecessary prescribing for primary prevention.


Sample Statin Prescribing Portrait - Mock Data (Apr 2012)



Statin Price Speedometer (Apr 2012)



Which Patients Benefit from Statin Therapy? (Apr 2012)


E-Appendix to Evaluation of the Statin Portrait (Aug 2012)





If you are interested in learning more about the evidence for using statins for primary and secondary prevention of coronary heart disease, the BC Provincial Academic Detailing (PAD) service provides free accredited educational sessions for individuals and small groups.

 For more information about the PAD service, or to arrange a session with the academic detailing pharmacist in your area, please visit

Please note that EQIP and the PAD service are separate programs. Academic Detailers do not have access to your EQIP prescribing portraits.